DENVER, July 13, 2021 /PRNewswire/ -- RAIsonance, Inc., a group of AI powered technology solutions companies which help to meet today's critical health and safety challenges headquartered in the Denver Tech Center, is proud to announce that it has seated its very first Medical Advisory Board to commence its two-year term, which started June, 2021.
The distinguished members include:
"We are incredibly gratified to have attracted such an esteemed team of brilliant medical professionals to serve on our Medical Advisory Board," said RAIsonance's Chief Medical Officer and Chief Strategy & Planning Officer Maurice Ramirez, DO, Ph.D. "With their guidance and support, we will be extremely well-positioned to bring our groundbreaking AI/ML technologies to market. As we seek to make a meaningful impact on the markets we serve, our Advisory Board will provide us with the essential insights we will need to make products that serve practitioners and patients all over the US, and indeed around the world."
Founded in 2020 in an effort to impact COVID-19 and partly funded by National Science Foundation, RAIsonance is structured as a group of separate companies dedicated to Artificial Intelligence/Machine Learning (AI/ML) based solutions for the safety, security, and healthcare diagnostics markets.
"We're incredibly fortunate to have the opportunity to work with and learn from these expert clinicians," said Kitty Kolding, CEO of RAIsonance, Inc. "Each individual brings unique perspective and invaluable expertise that will shape our product concepts and specialized technologies as we continue our work in health, wellness, biometrics and safety. It's hard to overstate how thrilled we are to be working with a team of advisors like this one."
For more information on RAIsonance, please visit www.RAIsonance.ai
About RAIsonance, Inc.
RAIsonance, Inc. is a family of companies headquartered in the Denver Tech Center in Colorado, dedicated to Artificial Intelligence/Machine Learning (AI/ML)-based solutions for the safety, security, and healthcare diagnostics markets. Partially funded with a grant from the National Science Foundation, RAIsonance has developed breakthrough technology innovations that use Signal Data Signature Recognition as a biomarker for human medical diagnostics and to support ground-breaking safety applications. To learn more about RAIsonance, please visit www.raisonance.ai
SOURCE RAIsonance, Inc.
© Copyright 2022 Feintuch Communications, Inc.
Site design by Bob Buchanan Design.
Photography and videography by Connor Leszczuk.
MediaRoom technology and hosting by PR Newswire.